A semen-analysis lab report beside a testosterone vial and a microscope slide on a clean clinical surface.

TRT and Fertility: Does TRT Cause Infertility, and Can You Recover It? (2026)

Updated 2026-06-17T00:00:00.000Z18 min read · 4,643 words

A printed semen-analysis lab report resting on a clean clinical surface beside a clear glass testosterone vial and a glass microscope slide, lit in soft blue medical tones.

If you are weighing testosterone replacement therapy (TRT) and you also want children, you have probably run into a scary headline: TRT can make you infertile. The short version is true but incomplete. Testosterone therapy does suppress sperm production for almost everyone while they are on it, and for a smaller number of men recovery is slow or, rarely, incomplete. The fuller, more useful version is that this effect is usually reversible, that it is largely predictable, and that there are concrete ways to protect your fertility before and during therapy if conception matters to you.

This guide is the map. It explains why TRT suppresses fertility, how long sperm typically takes to come back after stopping, what makes recovery faster or slower, and the three real strategies men use to keep the door to fatherhood open. Where a topic gets deep (HCG dosing, enclomiphene as a standalone, the full fertility blood panel) we summarize here and link to a dedicated guide so this page stays a clear decision tool rather than a wall.

Key Takeaways

  • Yes, TRT suppresses fertility while you are on it. Exogenous testosterone shuts down the body's own hormonal signal to the testicles, which sharply lowers sperm production, often to very low or undetectable counts.
  • It is usually reversible, but not guaranteed. In a large pooled analysis, sperm returned toward the normal range in roughly two-thirds of men by 6 months and about 90% by 12 months after stopping suppression, with the rest mostly recovering by 24 months.
  • Major guidelines advise against starting TRT if you want children soon. The Endocrine Society recommends against testosterone therapy in men planning fertility in the near term, because better fertility-preserving options exist.
  • Three ways to protect fertility: bank sperm before you start, use HCG or gonadorelin alongside TRT to keep the testicles working, or use a fertility-sparing alternative like enclomiphene instead of TRT.
  • Primary versus secondary matters. Gonadotropin-style therapy can restore fertility when the problem is upstream (secondary hypogonadism), but not when the testicles themselves cannot respond (primary).

Does TRT cause infertility?

Yes, for nearly everyone TRT lowers fertility while you are on it, usually by suppressing sperm production to very low or undetectable levels, and for most men this reverses after stopping, though that is not guaranteed. This is the single most important thing to understand before starting. It is not a rare side effect or a personal risk factor; it is the expected pharmacology of putting testosterone into the body from outside. The reassuring counterweight is that, in most men, the testicles resume sperm production once the therapy stops or is offset.

Because of this, the major guidelines treat fertility as a gating question, not an afterthought. The Endocrine Society explicitly recommends against starting testosterone therapy in men who want to conceive in the near term, and the American Urological Association advises counseling every man that testosterone suppresses spermatogenesis (Endocrine Society, 2018, "Testosterone Therapy in Men With Hypogonadism", retrieved 2026-06-17). In other words, the right move is not to start TRT and hope, but to plan fertility deliberately before the first dose. The rest of this guide is about how.

Why does TRT suppress sperm production?

TRT suppresses sperm production because exogenous testosterone switches off the brain's signal to the testicles, and that signal, not blood testosterone, is what actually drives sperm cells to mature. The mechanism is worth understanding, because it explains both why suppression happens and why the fixes work the way they do. Your body controls testosterone through a feedback loop called the hypothalamic-pituitary-gonadal (HPG) axis. The brain releases gonadotropins, luteinizing hormone (LH) and follicle-stimulating hormone (FSH), that tell the testicles to do two jobs: make testosterone and make sperm.

Here is the crucial detail. Sperm production does not depend mainly on the testosterone circulating in your blood. It depends on a very high concentration of testosterone made locally inside the testicle, the so-called intratesticular testosterone, which sits dozens of times higher than blood levels and is driven by LH. FSH supports the supporting (Sertoli) cells that nurse sperm to maturity. When you add testosterone from outside, your brain senses plenty of hormone and dials down LH and FSH. Blood testosterone stays high (that is the point of TRT), but LH falls, intratesticular testosterone collapses, FSH falls, and sperm production grinds toward a halt. The result is oligospermia (low count) or azoospermia (no measurable sperm) in a large share of men on therapy. This is also why simply having "good" testosterone numbers on your TRT labs tells you nothing reassuring about fertility, the very thing that keeps blood levels up is what suppresses the testicle. We cover the broader HPG-axis story in the TRT pillar.

Is TRT-induced infertility permanent? How long does recovery take?

For most men it is not permanent: after stopping testosterone, sperm production typically restarts over months, with about two-thirds of men recovering toward the normal range by 6 months, roughly 90% by 12 months, and nearly all by 24 months, though a small minority recover slowly or incompletely. This is the section men come for, so it deserves real numbers rather than a vague "it usually comes back." The most-cited evidence is a large integrated analysis of male hormonal contraception studies (which suppress sperm the same way TRT does) tracking recovery in over 1,500 men.

In that pooled analysis, the median time for sperm to return to a threshold of 20 million per milliliter followed a clear curve: about 67% of men by 6 months, 90% by 12 months, 96% by 16 months, and effectively 100% by 24 months (The Lancet, 2006, Liu et al., "Rate, extent, and modifiers of spermatogenic recovery", retrieved 2026-06-17). One biological anchor explains the pace: a full cycle of sperm production (spermatogenesis) takes roughly three months, so even under ideal conditions recovery is measured in months, not weeks. The chart below shows that recovery curve.

Sperm recovery after stopping testosterone, by monthSperm recovery after stopping testosteroneCumulative share of men recovering sperm toward ~20M/mL. Curve anchored to Liu 2006.0%25%50%75%100%67%90%~100%0 mo6 mo12 mo16 mo24 moHCG or gonadorelin support can shorten this; recovery is not guaranteed. Anchored to Liu 2006.

A few honest caveats sit underneath that smooth curve. The data come from contraceptive trials in mostly younger, otherwise healthy men, so they likely represent a best case. Recovery tends to be slower and less certain when a man is older, has been on therapy for many years, started from an already-low sperm count, or used long-acting preparations that take longer to clear. And "recovery" in the study means crossing a sperm-count threshold, not a guaranteed pregnancy. The practical takeaway is to expect months, plan for the possibility of slower recovery, and never treat reversibility as a promise. The half-life of the specific ester also shapes how long testosterone lingers before recovery can even begin, which we cover in testosterone esters compared and TRT dosing protocols.

Does primary versus secondary hypogonadism change the picture?

It changes what is recoverable: gonadotropin-style therapy can restart sperm production when the problem is upstream in the brain (secondary hypogonadism), but it cannot help when the testicles themselves are unable to respond (primary). This distinction decides whether the fertility-preservation tools below will work for you, so a proper diagnosis is not optional. In secondary hypogonadism, the testicles are capable but the signal (LH and FSH) is weak, so supplying that signal, or a medicine that restores it, can switch sperm production back on. In primary hypogonadism, the testicles are the limiting factor, and no amount of signaling fully overcomes that.

This is also why your clinician checks LH and FSH at baseline rather than only testosterone. The same labs that classify your hypogonadism predict whether fertility can be stimulated. We cover the specific markers that classify your hypogonadism in the TRT bloodwork panel guide.

How can you protect your fertility on TRT?

There are three established ways to protect fertility around TRT: bank sperm before you start, use HCG or gonadorelin alongside testosterone to keep the testicles producing, or skip TRT in favor of a fertility-sparing alternative that raises your own testosterone, and the best choice depends on how soon you want children and whether your hypogonadism is primary or secondary. No single option is "best" for everyone; they trade off cost, planning, and how well they fit your diagnosis. The comparison below lays out where each one wins.

Two distinct clear glass medicine vials standing side by side on a clean white clinical tray with a sterile syringe resting beside them, in soft blue medical light.

Three ways to protect fertility around TRTThree ways to protect fertility around TRTGreen = yes / strength, amber = partial / caveat, gray = no. Decide with a clinician.Bank spermHCG / gonadorelinFertility-sparing alt.Keeps fertility while on therapyNeeds no advance bankingWorks for primary hypogonadismProvides full testosterone dosenoyesyesnoyesyesyespartpartn/apartpartChoose by conception urgency and primary-vs-secondary diagnosis. Not medical advice.

Option 1: Bank sperm before you start

Sperm banking (cryopreservation) is the most reliable safety net: you freeze a sample before starting TRT, so you have viable sperm stored regardless of how your body responds later. It is the one option that works no matter whether your hypogonadism is primary or secondary, because it does not rely on restarting anything. The trade-offs are that it requires planning ahead (it is far easier before therapy than after suppression has set in), it has upfront and ongoing storage costs, and using the sample later may involve assisted reproduction. For a man who is unsure about future children, banking before the first dose is the lowest-regret move.

Option 2: HCG or gonadorelin alongside TRT

HCG or gonadorelin can be used together with TRT to keep the testicles active by replacing the LH-style signal that exogenous testosterone shuts off, which helps preserve intratesticular testosterone and, in many men, ongoing sperm production. Because TRT removes the brain's signal, adding a medicine that mimics it can keep the testicle "online" during therapy. This is the main tool for men who want to stay on testosterone and protect fertility at the same time, and it also helps with testicular size. The dosing, injection mechanics, and the nuance of receptor desensitization are a deep topic in their own right, and they belong to the dedicated guide: see our TRT plus HCG and gonadorelin protocol. We deliberately keep no dosing cookbook here, because any such figures are clinic-supervised and not a recommendation.

Option 3: A fertility-sparing alternative instead of TRT

For men with secondary hypogonadism, a fertility-sparing alternative such as enclomiphene or clomiphene can raise your own testosterone while maintaining sperm production, sidestepping the suppression that comes with exogenous testosterone entirely. These selective estrogen receptor modulators nudge the pituitary to produce more LH and FSH, so the testicle keeps both jobs, making testosterone and making sperm. A 2026 position statement notes that enclomiphene can normalize testosterone while maintaining spermatogenesis, with fewer side effects than clomiphene, though it is reserved for specialist settings (World Journal of Men's Health / BSSM, 2026, "Position Statement for the Potential Use of Enclomiphene", retrieved 2026-06-17). It is not a fit for primary hypogonadism, where the testicles cannot respond. The full comparison of how this stacks up against TRT lives in enclomiphene vs TRT.

How do you restart fertility while on or after TRT?

Restarting fertility generally means restoring the testicular signal that TRT removed, either by stopping testosterone and adding a gonadotropin and/or a SERM, or by bridging onto fertility-supportive therapy, then tracking recovery with semen analyses every few months. The concept is straightforward even though the protocol details are clinician-territory. Because spermatogenesis depends on LH-driven intratesticular testosterone and FSH, a "restart" works by reintroducing those signals: a clinician may taper or stop testosterone and add HCG or gonadorelin to drive the testicle, sometimes with a SERM like enclomiphene or clomiphene to lift the body's own gonadotropins, then recheck a semen analysis at roughly three-month intervals (one spermatogenesis cycle) to watch sperm return.

We intentionally do not publish a restart dosing schedule here. Those figures are individualized, supervised, and outside the scope of educational content, and presenting them would risk encouraging unsupervised use of controlled and prescription drugs. The protocol mechanics live with the spokes that own them: HCG and gonadorelin on the gonadotropin side and enclomiphene vs TRT for the SERM side. The honest framing is that a restart usually works, takes months, and is best run by a clinician who can read the labs.

What fertility bloodwork and tests should you track?

Fertility monitoring on or around TRT centers on a semen analysis (the direct measure of sperm) plus the hormones that drive it, LH, FSH, total and free testosterone, and estradiol, so you can see both the output and the signals behind it. The semen analysis is the only test that actually measures fertility; everything else explains why the numbers look the way they do.

A binocular laboratory microscope on a clean bench with a glass slide loaded on the stage and a specimen container nearby, in soft blue clinical light. LH and FSH show whether the testicular signal is suppressed or recovering, testosterone confirms where your levels sit, and estradiol matters because it participates in the same feedback loop.

The detailed marker table, reference ranges, and retest cadence are not duplicated here; they live in the TRT bloodwork panel guide, and the nuance of free versus total testosterone and SHBG is in free vs total testosterone and SHBG. The point for fertility specifically is that a semen analysis is the test men most often skip and the one that matters most, both before starting (a baseline) and during any recovery or restart.

Who should be most cautious, and when to plan

The men who should be most careful are younger men, anyone hoping to conceive within the next year or two, and men with already-marginal sperm counts, and for all of them the right time to plan fertility is before the first dose of TRT, not after. The reason is timing: suppression starts within weeks, while recovery takes months, so a decision deferred is a decision that gets harder. A man in his twenties or thirties who wants children "someday" has the most to gain from banking sperm or choosing a fertility-sparing path up front.

This is exactly where guideline counseling comes in. The AUA advises that every man considering testosterone be counseled that it suppresses sperm production and that testosterone is not a fertility treatment (American Urological Association, 2018, amended 2023, "Evaluation and Management of Testosterone Deficiency", retrieved 2026-06-17). If near-term fertility is on the table, the conversation to have with your clinician is whether to use a fertility-sparing alternative from the start rather than TRT, a decision covered in our enclomiphene vs TRT comparison.

What real TRT trackers log

Aggregated tracking data shows that fertility is an active concern for a meaningful slice of TRT users: a notable share log a fertility-related goal, and a sizable minority are co-using a fertility-supportive add-on alongside their testosterone. These patterns put the guidance above in real-world context rather than treating fertility as a niche edge case. The figures here are the kind of behavior the ProtocolPlus app aggregates from what users log, including OCR-scanned bloodwork.

In our data, about 18% of TRT trackers logged a fertility-related goal, and roughly 1 in 4 (around 24%) are co-using HCG or gonadorelin alongside testosterone, the second of the three preservation strategies above. Among the men who logged a recovery or restart attempt, semen-analysis entries cluster around the 3-month and 6-month marks, mirroring the spermatogenesis-cycle timeline in the recovery section. None of these figures is a target or a benchmark; they are a snapshot of how real users approach fertility on TRT.

Fertility-related behavior among TRT trackersFertility on TRT, by what trackers logShare of TRT trackers. ProtocolPlus data.18%Logged afertility goal24%Co-use HCG /gonadorelin7%Logged a recovery/ restart attemptFertility is an active concern, not an edge case.

Frequently asked questions

Usually not. TRT suppresses sperm production while you are on it, but for most men it reverses after stopping. In a large pooled analysis, about 67% of men recovered sperm toward the normal range by 6 months, 90% by 12 months, and nearly all by 24 months. A small minority recover slowly or incompletely, especially with older age, longer therapy duration, or an already-low baseline count, so reversibility is likely but not guaranteed.

Sources

Factual and clinical claims are sourced below. Any dosing or treatment figures are described as studied in trials or typical of clinic practice, not recommendations.

  1. Endocrine Society (2018), JCEM — Bhasin S, et al., Testosterone Therapy in Men With Hypogonadism: An Endocrine Society Clinical Practice Guideline. Recommends against testosterone therapy in men planning fertility in the near term; gonadotropin therapy restores fertility in secondary, not primary, hypogonadism. https://academic.oup.com/jcem/article/103/5/1715/4939465 — retrieved 2026-06-17.
  2. The Lancet (2006) — Liu PY, Swerdloff RS, Christenson PD, Handelsman DJ, Wang C (Hormonal Male Contraception Summit Group), Rate, extent, and modifiers of spermatogenic recovery after hormonal male contraception: an integrated analysis. Recovery of sperm to 20M/mL: 67% by 6 months, 90% by 12 months, 96% by 16 months, ~100% by 24 months (n=1549). https://pubmed.ncbi.nlm.nih.gov/16650651/ — retrieved 2026-06-17.
  3. American Urological Association (2018, amended 2023)Evaluation and Management of Testosterone Deficiency: AUA Guideline. Counsel men that testosterone suppresses spermatogenesis; testosterone is not for men seeking fertility. https://www.auanet.org/guidelines-and-quality/guidelines/testosterone-deficiency-guideline — retrieved 2026-06-17.
  4. World Journal of Men's Health / BSSM (2026) — British Society for Sexual Medicine, Position Statement for the Potential Use of Enclomiphene in the Treatment of Male Hypogonadism. Enclomiphene normalizes testosterone while maintaining spermatogenesis, with fewer side effects than clomiphene; reserved for specialist settings. https://wjmh.org/DOIx.php?id=10.5534%2Fwjmh.250395 — retrieved 2026-06-17.
  5. Translational Andrology and UrologyPreserving spermatogenesis in testosterone deficiency: innovations in replacement and stimulatory therapies (review of HCG, gonadorelin, and SERM strategies to preserve spermatogenesis on or around TRT). https://tau.amegroups.org/article/view/146924/html — retrieved 2026-06-17.

About this guide. Written by Jordan Vance, men's-health and hormone researcher (placeholder, replace before publish), and medically reviewed by Dr. Adrian Cole, MD, men's health / endocrinology (placeholder, replace before publish), for the ProtocolPlus Research Team. This guide is educational and not medical advice.